The Contribution of Hematopoietic Stem Cells to Beta-cell Replacement

Overview

Journal Curr Diab Rep

Publisher Current Science

Specialty Endocrinology

Date 2009 Mar 28

PMID 19323956

Citations 6

Authors

Valeria Sordi

Lorenzo Piemonti

Affiliations

Soon will be listed here.

Abstract

Hemopoietic stem cells (HSCs) are commonly used for curing malignant and nonmalignant hematopoiesis disorders. In recent years, HSC potential giving rise to multilineage progeny has been reported. This issue, together with their availability and number, has made them ideal candidates for beta-cell replacement in diabetic patients. HSC capacity to differentiate to insulin-producing cells has been at the center of debate for the past 5 years and it now seems that their role could more likely be that of helper cells able to facilitate survival or stimulate proliferation of endogenous beta cells. In addition, clinical studies are ongoing about the possible use of HSCs to stop autoimmune destruction at the onset of diabetes or to induce tolerance through microchimerism in pancreatic islet transplantation.

Citing Articles

Direct lineage tracing reveals Activin-a potential for improved pancreatic homing of bone marrow mesenchymal stem cells and efficient ß-cell regeneration in vivo.

Dadheech N, Srivastava A, Vakani M, Shrimali P, Bhonde R, Gupta S Stem Cell Res Ther. 2020; 11(1):327.

PMID: 32731883 PMC: 7393856. DOI: 10.1186/s13287-020-01843-z.

Direct comparison of the abilities of bone marrow mesenchymal versus hematopoietic stem cells to reverse hyperglycemia in diabetic NOD.SCID mice.

Arany E, Waseem M, Strutt B, Chamson-Reig A, Bernardo A, Eng E Islets. 2018; 10(4):137-150.

PMID: 30110202 PMC: 6281365. DOI: 10.1080/19382014.2018.1480285.

Nisshesha rechaka pranayama offers benefits through brief intermittent hypoxia.

Malshe P Ayu. 2012; 32(4):451-7.

PMID: 22661835 PMC: 3361916. DOI: 10.4103/0974-8520.96114.

Nutritional programming of pancreatic β-cell plasticity.

Hill D World J Diabetes. 2011; 2(8):119-26.

PMID: 21954415 PMC: 3180528. DOI: 10.4239/wjd.v2.i8.119.

The use of biomaterials in islet transplantation.

Borg D, Bonifacio E Curr Diab Rep. 2011; 11(5):434-44.

PMID: 21748257 PMC: 3167046. DOI: 10.1007/s11892-011-0210-2.

References

Han P, Hodge G, Story C, Xu X . Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation. Br J Haematol. 1995; 89(4):733-40. DOI: 10.1111/j.1365-2141.1995.tb08409.x. View

Berger M, Adams S, Tigges B, Sprague S, Wang X, Collins D . Differentiation of umbilical cord blood-derived multilineage progenitor cells into respiratory epithelial cells. Cytotherapy. 2006; 8(5):480-7. DOI: 10.1080/14653240600941549. View

Reyes M, Verfaillie C . Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci. 2001; 938:231-3; discussion 233-5. DOI: 10.1111/j.1749-6632.2001.tb03593.x. View

Voltarelli J, Couri C, Stracieri A, Oliveira M, Moraes D, Pieroni F . Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2007; 297(14):1568-76. DOI: 10.1001/jama.297.14.1568. View

Franco O, Steyerberg E, Hu F, Mackenbach J, Nusselder W . Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007; 167(11):1145-51. DOI: 10.1001/archinte.167.11.1145. View

Jiang Y, Jahagirdar B, Reinhardt R, Schwartz R, Keene C, Ortiz-Gonzalez X . Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418(6893):41-9. DOI: 10.1038/nature00870. View

Raetz E, Beatty P, Adams R . Treatment of severe Evans syndrome with an allogeneic cord blood transplant. Bone Marrow Transplant. 1997; 20(5):427-9. DOI: 10.1038/sj.bmt.1700907. View

Lechner A, Yang Y, Blacken R, Wang L, Nolan A, Habener J . No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes. 2004; 53(3):616-23. DOI: 10.2337/diabetes.53.3.616. View

Gao X, Song L, Shen K, Wang H, Niu W, Qin X . Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice. Biochem Biophys Res Commun. 2008; 371(1):132-7. DOI: 10.1016/j.bbrc.2008.04.033. View

10.

Ricordi C, Karatzas T, Selvaggi G, Neri J, Fernandez H, Ruiz M . Enhanced allograft acceptance by multiple infusions of donor bone marrow in humans. Transplant Proc. 1995; 27(6):3381. View

11.

Shapiro A, Ricordi C, Hering B, Auchincloss H, Lindblad R, Robertson R . International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006; 355(13):1318-30. DOI: 10.1056/NEJMoa061267. View

12.

Choi J, Uchino H, Azuma K, Iwashita N, Tanaka Y, Mochizuki H . Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia. 2003; 46(10):1366-74. DOI: 10.1007/s00125-003-1182-9. View

13.

Keymeulen B, Vandemeulebroucke E, Ziegler A, Mathieu C, Kaufman L, Hale G . Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med. 2005; 352(25):2598-608. DOI: 10.1056/NEJMoa043980. View

14.

Rao S, Peters S, Crittenden R, Stewart F, Ramshaw H, Quesenberry P . Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment. Exp Hematol. 1997; 25(2):114-21. View

15.

Lagasse E, CONNORS H, Reitsma M, Dohse M, Osborne L, Wang X . Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000; 6(11):1229-34. DOI: 10.1038/81326. View

16.

Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B . Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol. 2003; 21(7):763-70. DOI: 10.1038/nbt841. View

17.

DIppolito G, Diabira S, Howard G, Menei P, Roos B, Schiller P . Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci. 2004; 117(Pt 14):2971-81. DOI: 10.1242/jcs.01103. View

18.

Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson S, Li B . Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410(6829):701-5. DOI: 10.1038/35070587. View

19.

Zorina T, Subbotin V, Bertera S, Alexander A, Haluszczak C, Gambrell B . Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells. 2003; 21(4):377-88. DOI: 10.1634/stemcells.21-4-377. View

20.

Haller M, Viener H, Wasserfall C, Brusko T, Atkinson M, Schatz D . Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol. 2008; 36(6):710-5. PMC: 2444031. DOI: 10.1016/j.exphem.2008.01.009. View